Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2043 related articles for article (PubMed ID: 25754161)

  • 1. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
    Hong KD; Lee Y; Kim BH; Lee SI; Moon HY
    Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
    Chaudary N; Milosevic M; Hill RP
    Gynecol Oncol; 2011 Nov; 123(2):393-400. PubMed ID: 21839498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
    Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
    Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
    Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer.
    Song J; Chen W; Cui X; Huang Z; Wen D; Yang Y; Yu W; Cui L; Liu CY
    Theranostics; 2020; 10(5):2327-2341. PubMed ID: 32089745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer.
    Tacconi C; Ungaro F; Correale C; Arena V; Massimino L; Detmar M; Spinelli A; Carvello M; Mazzone M; Oliveira AI; Rubbino F; Garlatti V; Spanò S; Lugli E; Colombo FS; Malesci A; Peyrin-Biroulet L; Vetrano S; Danese S; D'Alessio S
    Cancer Res; 2019 Aug; 79(16):4196-4210. PubMed ID: 31239267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
    Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
    Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
    Decio A; Taraboletti G; Patton V; Alzani R; Perego P; Fruscio R; Jürgensmeier JM; Giavazzi R; Belotti D
    Am J Pathol; 2014 Apr; 184(4):1050-1061. PubMed ID: 24508126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.
    Li J; Ye L; Sun PH; Satherley L; Hargest R; Zhang Z; Jiang WG
    Cancer Genomics Proteomics; 2015; 12(6):339-45. PubMed ID: 26543080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
    Ji H; Cao R; Yang Y; Zhang Y; Iwamoto H; Lim S; Nakamura M; Andersson P; Wang J; Sun Y; Dissing S; He X; Yang X; Cao Y
    Nat Commun; 2014 Sep; 5():4944. PubMed ID: 25229256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
    Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
    Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting tumor growth of colorectal cancer by blocking the expression of vascular endothelial growth factor receptor 3 using interference vector-based RNA interference.
    Lui Z; Ma Q; Wang X; Zhang Y
    Int J Mol Med; 2010 Jan; 25(1):59-64. PubMed ID: 19956902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
    Zhu X; Sun L; Lan J; Xu L; Zhang M; Luo X; Gong J; Wang G; Yuan X; Hu J; Wang J
    Oncotarget; 2016 Jun; 7(24):36501-36509. PubMed ID: 27145366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.